Test that could identify signs of Alzheimer’s disease 20 years earlier greenlit for trials
The ability to test for signs of Alzheimer’s disease decades earlier could be a step closer with a…
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
Ad hoc announcement pursuant to Art. 53 LR FORTITUDE study met primary and key secondary endpoints of reduction…
AstraZeneca, Roche join forces to boost AI-based cancer pathology across Asia
AstraZeneca, Roche join forces to boost AI-based cancer pathology across Asia May 20, 2026 | Wednesday | News…
PRO-C3 Launched by Roche Diagnostics on cobas Analyzers
Summary:Nordic Bioscience’s PRO-C3 test, now launched globally by Roche Diagnostics on cobas analyzers, offers a validated and CE-approved…